META Pharmaceuticals participated in BioHK 2023 and the 8th China BioMed Innovation and Investment Conference in September

META Pharmaceuticals participated in BioHK 2023 and the 8th China BioMed Innovation and Investment Conference in September.

As one of the largest international biotechnology conferences in Asia, BIOHK2023, the Hong Kong International Biotechnology Forum, had its grand opening on September 13th and concluded successfully on September 16th.

On the first day of the conference, a number of government representatives and authoritative experts in the field of biology, including Mr. Leung Chun-ying, Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference (CPPCC) and Former Chief Executive of the HKSAR, Mr. Yu Chang-hai, Chairman of BIOHK2023, Dr. Bruce Beutler, winner of the Nobel Prize in Physiology or Medicine in 2011, and Sir Jonathan Symonds, Chair of GlaxoSmithKline PLC, attended the conference and delivered speeches.

This year's exhibition not only attracted nearly 200 exhibitors from home and abroad and Hong Kong, but also held high-end forums and seminars at the same time, organizing 24 symposiums, 4 summit forums, 3 seminars and 11 round tables. META PHARMACEUTICALS was also honored to be invited to participate in the conference and was recognized by professionals for its biology mechanisms and milestones achieved in its small molecule inhibitor development programs. Because of immunometabolism's great clinical potential, META was awarded the top 10 out of the 36 in the pitch session's company presentations.

The 8th China BioMed Innovation and Investment Conference

On the first day of the conference, He Wei, Vice Chairman of the Standing Committee of the National People's Congress and Chairman of the Chinese Peasants and Workers Democratic Party; Ding Jian, Dean of the School of Pharmacy of the University of the Chinese Academy of Sciences; Sun Lei, Director of the Center for the Technical Evaluation of Medical Devices and Deputy Secretary of the Party Committee of the State Drug Administration; and Song Ruilin, Executive Chairman of the China Association for the Promotion of Pharmaceutical Innovation, and other authoritative experts in the field of biomedicine, were invited to attend the conference

The conference focuses on the latest industrial policies and pharmaceutical R & D trends and investment and financing trends. Since its inception, the cumulative number of participants reached more than 24,000 people, this conference also hosted 6 roadshow panels, with nearly 100 companies participated.

META PHARMACEUTICALS is honored to participate in this conference, and is also recommended to participate in the roadshow with its high-quality pipeline projects. META's Chief of Staff, Mr.WANG Zijun Alex, gave a comprehensive report of META's pipeline development and preclinical drug efficacy on topic - "Pioneering New Medicine Treatment of Autoimmune Diseases by Targeting ImmunoMETAbolism" on September 26th. In addition, META also had valuable exchanges with experts in the biopharmaceutical industry and investment opportunities with financing experts.